Investigational New Drug Contract Development and Manufacturing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Investigational New Drug Contract Development and Manufacturing Market is expected to expand at a CAGR of 6% from 2022 to 2028.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides pharmaceutical manufacturing and development services. Companies operating in the pharmaceutical sector partner with contract development and manufacturing companies to outsource drug manufacturing and drug development.

Market Segments

By Product:

• Small Molecule
• Large Molecule

By Service:

• Contract Development
• Contract Manufacturing

By End-User:

• Pharmaceutical Companies
• Biotech Companies
• Others

Key Players

• Covance Inc.
• Charles River Laboratories Inc.
• Cambrex Corporation
• IQVIA Holdings Inc.
• Syneos Health
• Lonza
• Catalent
• Recipharm AB
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.

Scope of the Report

The research study analyzes the global Investigational New Drug Contract Development and Manufacturing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Investigational New Drug Contract Development and Manufacturing Market Report

1. What was the Investigational New Drug Contract Development and Manufacturing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Investigational New Drug Contract Development and Manufacturing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Investigational New Drug Contract Development and Manufacturing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.